TY - JOUR
T1 - [18F]FDG PET/CT in the staging of inflammatory breast cancer
T2 - A systematic review
AU - van Uden, D. J.P.
AU - Prins, M. W.
AU - Siesling, S.
AU - de Wilt, J. H.W.
AU - Blanken-Peeters, C. F.J.M.
N1 - Elsevier deal
PY - 2020/7/1
Y1 - 2020/7/1
N2 - Up to 78 % of patients with inflammatory breast cancer (IBC) present with axillary lymph node involvement and up to 40 % with distant metastases. Previous studies indicate that 2-deoxy-2-(18F)fluoro-D-glucose ([18F]FDG) positron emission tomography/computed tomography (PET/CT) might be used for initial staging in patients with inflammatory breast cancer (IBC). In other cancer types, [18F]FDG PET/CT has been demonstrated to be a sensitive technique, providing complementary information on locoregional and distant disease to conventional imaging modalities. This systematic review showed that 18F]FDG PET/CT detects additional locoregional lymph node metastases and distant metastases in 10.3 % of patients, that were not detected with standard staging imaging. Compared with conventional imaging procedures, [18F]FDG PET/CT had better diagnostic performance for detection of locoregional and distant metastases and should standardly be used in the diagnostic work-up of IBC patients.
AB - Up to 78 % of patients with inflammatory breast cancer (IBC) present with axillary lymph node involvement and up to 40 % with distant metastases. Previous studies indicate that 2-deoxy-2-(18F)fluoro-D-glucose ([18F]FDG) positron emission tomography/computed tomography (PET/CT) might be used for initial staging in patients with inflammatory breast cancer (IBC). In other cancer types, [18F]FDG PET/CT has been demonstrated to be a sensitive technique, providing complementary information on locoregional and distant disease to conventional imaging modalities. This systematic review showed that 18F]FDG PET/CT detects additional locoregional lymph node metastases and distant metastases in 10.3 % of patients, that were not detected with standard staging imaging. Compared with conventional imaging procedures, [18F]FDG PET/CT had better diagnostic performance for detection of locoregional and distant metastases and should standardly be used in the diagnostic work-up of IBC patients.
KW - Positron emission tomography
KW - Staging
KW - Inflammatory breast cancer
KW - 22/2 OA procedure
UR - http://www.scopus.com/inward/record.url?scp=85084491244&partnerID=8YFLogxK
U2 - 10.1016/j.critrevonc.2020.102943
DO - 10.1016/j.critrevonc.2020.102943
M3 - Review article
C2 - 32416347
AN - SCOPUS:85084491244
VL - 151
JO - Critical Reviews in Oncology/Hematology
JF - Critical Reviews in Oncology/Hematology
SN - 1040-8428
M1 - 102943
ER -